105 related articles for article (PubMed ID: 14644329)
1. Enhanced sensitivity of peripheral blood lymphocytes from women carrying a BRCA1 mutation towards the mutagenic effects of various cytostatics.
Trenz K; Lugowski S; Jahrsdörfer U; Jainta S; Vogel W; Speit G
Mutat Res; 2003 Nov; 544(2-3):279-88. PubMed ID: 14644329
[TBL] [Abstract][Full Text] [Related]
2. Chromosomal mutagen sensitivity associated with mutations in BRCA genes.
Speit G; Trenz K
Cytogenet Genome Res; 2004; 104(1-4):325-32. PubMed ID: 15162060
[TBL] [Abstract][Full Text] [Related]
3. Mutagen sensitivity of peripheral blood from women carrying a BRCA1 or BRCA2 mutation.
Trenz K; Rothfuss A; Schütz P; Speit G
Mutat Res; 2002 Mar; 500(1-2):89-96. PubMed ID: 11890937
[TBL] [Abstract][Full Text] [Related]
4. Induced micronucleus frequencies in peripheral lymphocytes as a screening test for carriers of a BRCA1 mutation in breast cancer families.
Rothfuss A; Schütz P; Bochum S; Volm T; Eberhardt E; Kreienberg R; Vogel W; Speit G
Cancer Res; 2000 Jan; 60(2):390-4. PubMed ID: 10667592
[TBL] [Abstract][Full Text] [Related]
5. Mutagen sensitivity of human lymphoblastoid cells with a BRCA1 mutation.
Trenz K; Landgraf J; Speit G
Breast Cancer Res Treat; 2003 Mar; 78(1):69-79. PubMed ID: 12611459
[TBL] [Abstract][Full Text] [Related]
6. Ionizing radiation or mitomycin-induced micronuclei in lymphocytes of BRCA1 or BRCA2 mutation carriers.
Gutiérrez-Enríquez S; Ramón Y Cajal T; Alonso C; Corral A; Carrasco P; Cornet M; Sanz J; Ribas M; Baiget M; Diez O
Breast Cancer Res Treat; 2011 Jun; 127(3):611-22. PubMed ID: 20625817
[TBL] [Abstract][Full Text] [Related]
7. Mutagen sensitivity of human lymphoblastoid cells with a BRCA1 mutation in comparison to ataxia telangiectasia heterozygote cells.
Speit G; Trenz K; Schütz P; Bendix R; Dörk T
Cytogenet Cell Genet; 2000; 91(1-4):261-6. PubMed ID: 11173867
[TBL] [Abstract][Full Text] [Related]
8. Increased rates of spontaneous sister chromatid exchange in lymphocytes of BRCA2+/- carriers of familial breast cancer clusters.
Kim MK; Zitzmann S; Westermann F; Arnold K; Brouwers S; Schwab M; Savelyeva L
Cancer Lett; 2004 Jul; 210(1):85-94. PubMed ID: 15172125
[TBL] [Abstract][Full Text] [Related]
9. Lymphocytes of BRCA1 and BRCA2 germ-line mutation carriers, with or without breast cancer, are not abnormally sensitive to the chromosome damaging effect of moderate folate deficiency.
Beetstra S; Salisbury C; Turner J; Altree M; McKinnon R; Suthers G; Fenech M
Carcinogenesis; 2006 Mar; 27(3):517-24. PubMed ID: 16162645
[TBL] [Abstract][Full Text] [Related]
10. Evidence that BRCA1- or BRCA2-associated cancers are not inevitable.
Levin B; Lech D; Friedenson B
Mol Med; 2012 Dec; 18(1):1327-37. PubMed ID: 22972572
[TBL] [Abstract][Full Text] [Related]
11. Detection of aneugenic and clastogenic potential of X-rays, directly and indirectly acting chemicals in human hepatoma (Hep G2) and peripheral blood lymphocytes, using the micronucleus assay and fluorescent in situ hybridization with a DNA centromeric probe.
Darroudi F; Meijers CM; Hadjidekova V; Natarajan AT
Mutagenesis; 1996 Sep; 11(5):425-33. PubMed ID: 8921503
[TBL] [Abstract][Full Text] [Related]
12. The relationship between sister chromatid exchange induction and leukemogenicity of different cytostatics.
Raposa T; Várkonyi J
Cancer Detect Prev; 1987; 10(1-2):141-51. PubMed ID: 3568006
[TBL] [Abstract][Full Text] [Related]
13. DNA repair capacity as a possible biomarker of breast cancer risk in female BRCA1 mutation carriers.
Kotsopoulos J; Chen Z; Vallis KA; Poll A; Ainsworth P; Narod SA
Br J Cancer; 2007 Jan; 96(1):118-25. PubMed ID: 17213827
[TBL] [Abstract][Full Text] [Related]
14. The Chinese hamster FANCG/XRCC9 mutant NM3 fails to express the monoubiquitinated form of the FANCD2 protein, is hypersensitive to a range of DNA damaging agents and exhibits a normal level of spontaneous sister chromatid exchange.
Wilson JB; Johnson MA; Stuckert AP; Trueman KL; May S; Bryant PE; Meyn RE; D'Andrea AD; Jones NJ
Carcinogenesis; 2001 Dec; 22(12):1939-46. PubMed ID: 11751423
[TBL] [Abstract][Full Text] [Related]
15. Increased chromosomal radiosensitivity in women carrying BRCA1/BRCA2 mutations assessed with the G2 assay.
Ernestos B; Nikolaos P; Koulis G; Eleni R; Konstantinos B; Alexandra G; Michael K
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1199-205. PubMed ID: 20206018
[TBL] [Abstract][Full Text] [Related]
16. Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium.
Lancet; 1997 May; 349(9064):1505-10. PubMed ID: 9167459
[TBL] [Abstract][Full Text] [Related]
17. Chromosomal instability in mutagen-sensitive mutants isolated from mouse lymphoma L5178Y cells. II. Abnormal induction of sister-chromatid exchanges and chromosomal aberrations by mutagens in an ionizing radiation-sensitive mutant (M10) and an alkylating agent-sensitive mutant (MS1).
Tsuji H; Takahashi E; Tsuji S; Tobari I; Shiomi T; Sato K
Mutat Res; 1987 May; 178(1):107-16. PubMed ID: 3106796
[TBL] [Abstract][Full Text] [Related]
18. Radiosensitivity of lymphoblastoid cell lines with a heterozygous BRCA1 mutation is not detected by the comet assay and pulsed field gel electrophoresis.
Trenz K; Schütz P; Speit G
Mutagenesis; 2005 Mar; 20(2):131-7. PubMed ID: 15784691
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
20. BRCA1 regulates RAD51 function in response to DNA damage and suppresses spontaneous sister chromatid replication slippage: implications for sister chromatid cohesion, genome stability, and carcinogenesis.
Cousineau I; Abaji C; Belmaaza A
Cancer Res; 2005 Dec; 65(24):11384-91. PubMed ID: 16357146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
